课题基金 / 基金详情

Functional Interaction Between T-cell and B-cell Immune Pathways in Neuro- inflammatory Disorders

Functional Interaction Between T-cell and B-cell Immune Pathways in Neuro- inflammatory Disorders
神经炎症性疾病中 T 细胞和 B 细胞免疫途径之间的功能相互作用
批准号:
9332909
负责人:
Robert C Axtell
金额:
$64.61万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2018-08-31

项目摘要

项目成果

Robert C Axtell的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):视神经肌萎缩症(NMO)是一种罕见但破坏性的中枢神经系统(CNS)炎症性疾病,主要影响视神经和脊髓。NMO最初被描述为多发性硬化症(MS)的一个子集,但现在被认为是一种独特的疾病。目前,还没有FDA批准的NMO治疗方法。事实上,许多MS疗法,最显著的是干扰素-β(IFN-β),抑制NMO。NMO的有限治疗表明,这种疾病在神经病学方面有明显的未满足的需求。该项目的目标是了解在NMO中启动疾病活动的免疫途径。该提案的目的将解决三个相互关联但不同的问题,这些问题将对NMO患者产生影响。目的1将确定MS和NMO患者中存在的免疫途径。这将通过血浆蛋白质组学分析和患者CD 4 + T细胞和B细胞的转录组学分析来实现。目的2:利用细胞培养技术,研究NMO和健康志愿者B细胞亚群与T辅助细胞之间的直接相互作用。目的3将利用我们已经开发的动物模型来理解BAFF和APRIL在神经自身免疫性疾病中对T细胞、中性粒细胞和B细胞相互作用的潜在作用机制。该提案的前两个目标将是Axtell,Lessard,Pardo(OMRF MS卓越中心主任),Anaya(罗萨里奥大学医学教授,自身免疫疾病研究中心主任)和加速治愈项目(ACP)之间的高度翻译合作。Pardo博士、Anaya博士和ACP将为该项目提供的临床专业知识和大量患者人群将使这些目标得以实现。第三个目标是利用我们在神经自身免疫动物模型中的优势,深入了解NMO背后的生物学机制。本提案中概述的对人类受试者的研究和机械动物实验的结合有可能深入了解NMO的病理过程。
英文摘要
 DESCRIPTION (provided by applicant): Neuromyelitis optica (NMO) is a rare but devastating inflammatory disorder of the central nervous system (CNS) that primarily affects the optic nerves and spinal cord. NMO was initially characterized as a subset of multiple sclerosis (MS), but is now considered a distinct disease. Currently, there are no FDA approved therapies for NMO. In fact, many MS therapies, most notably interferon-beta (IFN-β), worsens NMO. The limited therapies for NMO demonstrate that this disease has clear unmet needs in neurology. The goal of this project is to understand the immune pathways that initiate disease activity in NMO. The aims of this proposal will address three connected but distinct issues that will have an impact NMO patients. Aim 1 will determine the immune pathways that are present in patients with MS and NMO. This will be achieved by proteomic analysis of plasma and transcriptomic analysis of CD4+ T-cells and B-cells from patients. Aim 2 will assess the direct interaction between B-cell subsets and T helper cells from NMO and healthy volunteers by utilizing cell culturing techniques. Aim 3 will utilize the animal models we have developed to understand the mechanisms underlying the effects BAFF and APRIL have on T cells, neutrophil and B-cells interactions in neuro- autoimmune disease. The first two aims of this proposal will be a highly translation collaboration between Drs. Axtell, Lessard, Pardo (the director of OMRF's MS Center of Excellence), Anaya (Professor of Medicine at Rosario University, Director of the Autoimmune Diseases Research Center) and the Accelerated Cure Project (ACP). The clinical expertise and large patient population Drs. Pardo, Anaya and the ACP will provide to this project will enable these aims to be accomplished. The third aim utilizes our strength in animal models of neuro-autoimmunity that will give insight into the biological mechanisms behind NMO. The combination of research on human subject and the mechanistic animal experiments outlined in this proposal have the potential to give deep insight into pathological processes that underlie and NMO.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the roles type I Interferon and TH17 play in Neuromyelitis Optica and other autoimmune diseases.
Understanding the roles type I Interferon and TH17 play in Neuromyelitis Optica and other autoimmune diseases.
Pathogenic B cell and T helper cell interactions in Neuromyelitis Optica
Pathogenic B cell and T helper cell interactions in Neuromyelitis Optica
海外基金